Why This Matters
Finasteride is one of the most prescribed drugs for male pattern hair loss in the UK. Millions of men take it. A significant proportion of those men are also interested in testosterone optimisation — either through lifestyle, supplementation, or TRT.
The overlap between "man taking finasteride for hair loss" and "man concerned about testosterone" is enormous. Yet the interaction between finasteride and testosterone, and the full picture of what finasteride does to androgenic hormones, is poorly explained in most hair loss and TRT resources.
This is the complete guide.
What Finasteride Does
Finasteride is a 5-alpha reductase (5-AR) inhibitor. It works by blocking the enzyme 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT).
DHT is a potent androgen — approximately 3–5 times more potent than testosterone at the androgen receptor. In scalp hair follicles, DHT binding triggers miniaturisation — the follicle shrinks over time until it can no longer produce visible hair. Blocking DHT production prevents this process.
Finasteride (1mg, marketed as Propecia; 5mg as Proscar for prostate enlargement) reduces serum DHT by approximately 70% at the 1mg dose and 85–90% at the 5mg dose.
What Happens to Testosterone When You Take Finasteride
When DHT production is blocked, testosterone — which would have been converted to DHT — accumulates upstream. Several hormonal changes occur:
Total testosterone rises. Studies consistently show total testosterone increases of 10–15% in men on finasteride, because testosterone that would have become DHT remains as testosterone. This sounds like a benefit, but the picture is more complex.
Free testosterone rises modestly. Some of the increased testosterone remains unbound. Free testosterone may increase slightly.
Oestradiol may rise. With more testosterone available (and not converting to DHT), there is more substrate for aromatase to convert testosterone to oestradiol. Men on finasteride sometimes see oestradiol elevation over time. This can cause: reduced libido, emotional flatness, water retention, and gynecomastia — symptoms that are often misattributed to the drug directly rather than to the oestradiol elevation.
DHT plummets. The most significant effect. DHT drives: libido (more potently than testosterone), assertiveness, body composition (fat distribution, muscle density), skin oil production, and the sexual effects that many men describe as their sense of "drive." DHT deficiency — which is what finasteride creates — produces symptoms including reduced libido, erectile dysfunction, brain fog, and mood changes.
The paradox: Total testosterone rises on finasteride, but the actual androgenic effect on the body may be reduced because DHT — the more potent androgen for many tissue effects — is suppressed.
Finasteride Side Effects: What the Research Shows vs. What Men Report
The official clinical trial data for finasteride shows sexual side effects in approximately 2–4% of men, which resolves on discontinuation. This has been the standard reassurance given for decades.
The real-world picture is more complicated.
The MPMD/post-finasteride syndrome debate: A significant and vocal community of men report persistent sexual, cognitive, and hormonal side effects that continue long after stopping finasteride. This is termed Post-Finasteride Syndrome (PFS). The FDA updated the Propecia label in 2012 to include warnings about persistent sexual dysfunction after discontinuation.
The research on PFS is contested and ongoing — some studies find no evidence of persistent effects; others find neurological and hormonal changes in affected men. The Post-Finasteride Syndrome Foundation has sponsored research at major universities.
What the evidence supports:
- Sexual side effects during finasteride use: real and more common than initial clinical trial data suggested (some studies show 10–15% of men experience them)
- Reversal on discontinuation in most men: usually within weeks to months
- Persistent effects in a minority: real but poorly characterised, likely 1–3% of men who experience side effects
What the evidence doesn't resolve:
- The exact mechanism of PFS if it occurs
- Why some men are affected persistently while others aren't
- Whether neurosteroid changes (DHT is a precursor to neurosteroids including allopregnanolone) explain the persistent symptoms
Finasteride and TRT: The Interaction
Men on TRT who also take finasteride create an unusual hormonal environment:
TRT raises testosterone → more substrate for both DHT and oestrogen conversion. On TRT alone, DHT rises alongside testosterone. On TRT + finasteride, DHT is suppressed despite the higher testosterone — oestrogen conversion increases further.
The clinical picture: Men on TRT + finasteride often require closer oestradiol monitoring and may need aromatase inhibitor support. The loss of DHT's direct androgenic effects may reduce the full benefit of TRT — libido improvements from TRT are partly DHT-mediated, and suppressing DHT alongside TRT may blunt this effect.
Some TRT clinics will not prescribe finasteride alongside TRT for this reason. Others will manage it with careful oestradiol monitoring and sometimes dutasteride-only regimes at lower dose.
Dutasteride: Finasteride's More Aggressive Cousin
Dutasteride inhibits both type 1 and type 2 5-alpha reductase (finasteride only inhibits type 2). It reduces DHT by approximately 95% — significantly more than finasteride.
Dutasteride is not licensed for hair loss in the UK (it's licensed only for BPH — benign prostatic hyperplasia — at 0.5mg). However, it's prescribed off-label for androgenic alopecia by some dermatologists and private clinics.
For the same reasons that apply to finasteride, the interaction with testosterone and TRT is relevant — amplified, given the higher DHT suppression. Men considering dutasteride alongside TRT should have experienced medical oversight and close hormonal monitoring.
The Hair Loss–Testosterone Dilemma
This is the core dilemma many men over 40 face: androgenic alopecia (male pattern baldness) is driven by DHT in genetically susceptible individuals. The same DHT that causes scalp hair loss is the androgen that drives libido, assertiveness, and some of the qualities men want to maintain or restore.
TRT worsens hair loss in men who are genetically predisposed — by raising testosterone (and thus DHT) above baseline. This is one of the most common concerns men raise before starting TRT.
The honest conversation:
- If you have the genes for androgenic alopecia, higher DHT will accelerate hair loss
- TRT at standard doses typically raises DHT modestly — not dramatically
- Some men choose to accept accelerated hair loss as a trade-off for the benefits of TRT
- Others take finasteride or dutasteride to protect hair while on TRT (accepting the hormonal trade-offs)
- A third approach: topical finasteride or dutasteride (applied to the scalp only) limits systemic DHT suppression while reducing scalp DHT — this is available from private clinics (Clinic 33, Sons, MANUAL in the UK)
Topical finasteride reduces scalp DHT while causing less systemic suppression than oral finasteride. Blood DHT levels are lower than without treatment but not suppressed to the same degree as oral. This is increasingly the preferred approach for men who want hair preservation without full systemic DHT suppression.
What to Do If You're Currently on Finasteride
If asymptomatic and happy with finasteride: No action required. Monitor oestradiol if you add TRT. Discuss with your TRT clinic before starting testosterone therapy.
If experiencing side effects on finasteride: Discuss with the prescribing doctor. The side effects may be DHT-mediated (the drug is working as intended but producing androgenic deficit symptoms) or oestrogen-mediated (aromatase shift). A hormone panel — testosterone, DHT, oestradiol — guides the response.
If considering finasteride to protect hair while on TRT: Discuss the options carefully with your TRT clinic. Topical finasteride, close oestradiol monitoring, and potentially lower TRT dose to minimise total DHT elevation are all considerations.
If you took finasteride previously and have persistent concerns: The PFS Foundation website provides research updates. A full hormone panel including neurosteroid markers (available from specialist labs) may provide information, though treatment options for PFS remain limited and poorly validated.
Key Blood Markers to Monitor on Finasteride
- DHT — confirm suppression level and monitor for excessive suppression
- Total and free testosterone — baseline and periodic monitoring
- Oestradiol — watch for elevation due to increased aromatase substrate
- LH and FSH — ensure HPG axis signalling remains appropriate
- Prolactin — occasionally elevated in men with significant hormonal disruption
A comprehensive Medichecks panel covers all of the above.
The Short Version
Finasteride reduces DHT by 70–90%. Total testosterone rises on finasteride but the androgen effect on the body may be reduced because DHT — the more potent tissue androgen — is suppressed. Sexual side effects occur in more men than initial clinical trials suggested; most resolve on stopping, a minority report persistent effects. On TRT, finasteride further complicates the hormonal picture — oestradiol management becomes more critical. Topical finasteride is the preferred modern approach for men who want hair preservation without full systemic DHT suppression. Get a full hormone panel before and during finasteride use.